Clinical Trials on Depression in Ireland

Total 309 results

Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Major Depressive Disorder

United States
GlaxoSmithKline

Terminated

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder (orvepitant MDD)

Depressive Disorder, Major

United States, Canada
BRC Operations Pty. Ltd.

Unknown

International Study to Predict Optimised Treatment - in Depression (iSPOT-D)

Major Depressive Disorder

United States, Australia, Netherlands, New Zealand, South Africa
Woebot Health
Iqvia Pty Ltd

Terminated

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

Postpartum Depression

United States
Vanda Pharmaceuticals

Completed

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder (MAGELLAN)

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

MDD

United States
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States, Japan
H. Lundbeck A/S

Completed

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

Major Depression Disorder

Germany, United States, Estonia, Finland, Poland
Alkermes, Inc.

Completed

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study

Major Depressive Disorder

United States, Australia, Canada
Dublin City University

Completed

Exploring the Effectiveness of the 'Back of the Net' Intervention on Indices of Physical and Psychological Measures (BTN)

Depression | Self Concept | Body Fat Composition | Perceived Social Support

Ireland
Avanir Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Depressive Disorder, Treatment-Resistant

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (STEP-D222)

Major Depressive Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals

Completed

Study Evaluating Bifeprunox in Bipolar Depression

Depression Bipolar

United States
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH)

Completed

Research Evaluating the Value of Augmenting Medication With Psychotherapy (REVAMP)

Depressive Disorder | Depression

United States
Shire

Completed

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States, Spain, Canada, Puerto Rico, Croatia, Mexico
Pfizer

Completed

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Major Depressive Disorder

United States, Chile, Mexico
Pfizer

Completed

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Major Depressive Disorder

United States, Chile
Wyeth is now a wholly owned subsidiary of Pfizer
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder

Major Depressive Disorder

United States
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States, India, Puerto Rico
Brown University

Completed

Group Therapy for Women Prisoners With Comorbid Substance Use and Depression

Depressive Disorder | Substance Abuse | Substance Dependence

United States
BlackThorn Therapeutics, Inc.
Neumora Therapeutics, Inc.

Completed

Study in Major Depressive Disorder With BTRX-335140 (NMRA-335140) vs Placebo

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study in Depression and Associated Painful Physical Symptoms

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories

Completed

Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States, Canada
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)

Depression | HIV Infections | HIV

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, Germany, Poland, Hungary, Slovakia
Alto Neuroscience

Recruiting

Study of ALTO-300 in MDD

Major Depressive Disorder

United States
Forest Laboratories

Completed

Safety Study of F2695 SR in Major Depressive Disorder (LVM-MD-04)

Major Depressive Disorder

United States
Sirtsei Pharmaceuticals, Inc.

Completed

A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States
AstraZeneca

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder (DIAMOND)

Major Depressive Disorder

United States
Biohaven Therapeutics Ltd.

Recruiting

Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

Major Depressive Disorder

United States
Euthymics BioScience, Inc.

Completed

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Major Depressive Disorder

United States
Janssen Research & Development, LLC

Completed

A Study of JNJ-61393215 in the Treatment of Depression

Major Depressive Disorder With Anxious Distress

United States, Moldova, Republic of, Russian Federation, Ukraine, United Kingdom
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

Major Depressive Disorder

United States
Bristol-Myers Squibb

Completed

Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Major Depressive Disorder

United Kingdom, United States, Belgium, Austria, Australia, Germany, Sweden
Hoffmann-La Roche

Completed

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Major Depressive Disorder

Germany, United States, Taiwan, Mexico, Poland, Russian Federation, Chile, Japan, Romania
Butler Hospital

Completed

Treating Comorbid Pain and Depression in HIV+ Individuals (HIVPass)

Depression | Pain | HIV

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

Bipolar Disorder | Depression, Bipolar

United States, Australia, India
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Sunovion

Completed

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose (RESOLVE 1)

Major Depressive Disorder With Mixed Features

United States, Serbia, Ukraine, Russian Federation, United Kingdom
Solveig Magnusdottir
Menntaskolin a Akureyri

Enrolling by invitation

Behavioral and Sleep Hygiene Education With Mindfulness Intervention to Improve Sleep Regularity in Adolescents

Depression | Sleep | Anxiety | Chronotype

Iceland
Repligen Corporation

Completed

A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

Bipolar I Depression

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Anxiety | Major Depressive Disorder

United States
AstraZeneca

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder (MOONSTONE)

Major Depressive Disorder

United States
ACADIA Pharmaceuticals Inc.

Completed

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Adjunctive Treatment of Major Depressive Disorder

United States
Rhode Island Hospital
Brown University

Unknown

Treatment of Conduct Problems and Depression

Depression | Conduct Disorder | Oppositional Defiant Disorder

United States
Eli Lilly and Company

Completed

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories

Completed

Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder (VLZ-MD-21)

Major Depressive Disorder

United States
Takeda

Terminated

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Acute Depressive Episode

United States, Argentina, Chile, Colombia, Mexico

3

Subscribe